These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28500654)

  • 1. Altered timing of riboflavin and ultraviolet light pathogen inactivation improves platelet in vitro quality.
    Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Yi Q; Thiele T; Greinacher A; Marschner S; Devine DV
    Transfusion; 2017 Aug; 57(8):2026-2034. PubMed ID: 28500654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
    Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Bu D; Bhakta V; Sheffield WP; Goodrich RP; Devine DV
    Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres.
    van der Meer PF; Couture C; Hervig T; Kruit G; Devine DV; de Korte D; Kerkhoffs JL
    Vox Sang; 2017 Jan; 112(1):9-17. PubMed ID: 28001293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage.
    Schubert P; Culibrk B; Coupland D; Scammell K; Gyongyossy-Issa M; Devine DV
    Transfusion; 2012 Feb; 52(2):397-408. PubMed ID: 21827504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment.
    Chen Z; Schubert P; Culibrk B; Devine DV
    Transfusion; 2015 Apr; 55(4):848-57. PubMed ID: 25385501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 mitogen-activated protein kinase regulates mitochondrial function and microvesicle release in riboflavin- and ultraviolet light-treated apheresis platelet concentrates.
    Chen Z; Schubert P; Bakkour S; Culibrk B; Busch MP; Devine DV
    Transfusion; 2017 May; 57(5):1199-1207. PubMed ID: 28236306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
    Ruane PH; Edrich R; Gampp D; Keil SD; Leonard RL; Goodrich RP
    Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution?
    van der Meer PF; Bontekoe IJ; Daal BB; de Korte D
    Transfusion; 2015 Aug; 55(8):1900-8. PubMed ID: 25752624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.
    Abonnenc M; Sonego G; Crettaz D; Aliotta A; Prudent M; Tissot JD; Lion N
    Transfusion; 2015 Sep; 55(9):2219-30. PubMed ID: 25873361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment.
    Schubert P; Coupland D; Culibrk B; Goodrich RP; Devine DV
    Transfusion; 2013 Dec; 53(12):3164-73. PubMed ID: 23521225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling.
    Reid S; Johnson L; Woodland N; Marks DC
    Transfusion; 2012 Oct; 52(10):2094-103. PubMed ID: 22320126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets.
    Bashir S; Cookson P; Wiltshire M; Hawkins L; Sonoda L; Thomas S; Seltsam A; Tolksdorf F; Williamson LM; Cardigan R
    Transfusion; 2013 May; 53(5):990-1000. PubMed ID: 22905813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboflavin and ultraviolet illumination affects selected platelet mRNA transcript amounts differently.
    Klein-Bosgoed C; Schubert P; Devine DV
    Transfusion; 2016 Sep; 56(9):2286-95. PubMed ID: 27443848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of platelets with riboflavin and ultraviolet light mediates complement activation and suppresses monocyte interleukin-12 production in whole blood.
    Loh YS; Dean MM; Johnson L; Marks DC
    Vox Sang; 2015 Nov; 109(4):327-35. PubMed ID: 25975771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Releasates of riboflavin/UV-treated platelets: Microvesicles suppress cytokine-mediated endothelial cell migration/proliferation.
    Schubert P; Culibrk L; Culibrk B; Conway EM; Goodrich RP; Devine DV
    Transfusion; 2021 May; 61(5):1551-1561. PubMed ID: 33629371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV light.
    Ballester-Servera C; Jimenez-Marco T; Morell-Garcia D; Quetglas-Oliver M; Bautista-Gili AM; Girona-Llobera E
    Blood Transfus; 2020 Jul; 18(4):280-289. PubMed ID: 32530405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.
    Picker SM; Schneider V; Gathof BS
    Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days.
    Cookson P; Thomas S; Marschner S; Goodrich R; Cardigan R
    Transfusion; 2012 May; 52(5):983-94. PubMed ID: 22014032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed xenon flash treatment inactivates bacteria in apheresis platelet concentrates while preserving in vitro quality and functionality.
    Abe H; Shiba M; Niibe Y; Tadokoro K; Satake M
    Transfusion; 2017 Apr; 57(4):989-996. PubMed ID: 28084008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.